Related Experiment Video
Updated: Jan 7, 2026

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.8K
Insights Into Macrophage Ferroptosis: Implications for Atherosclerosis
Xiehui Chen1,2, Xiangbo Liu3, Changchun Zeng4
1Department of Geriatrics, Shenzhen Longhua District Central Hospital, Shenzhen, China.
Cell Proliferation
|December 29, 2025
Summary
Ferroptosis, an iron-dependent cell death, drives atherosclerosis by impacting macrophages and vascular cells. Inhibiting this process may stabilize plaques and reduce cardiovascular events.
Area of Science:
- Cardiovascular Research
- Cellular Biology
- Immunology
Background:
- Atherosclerosis is a major health issue driven by lipid metabolism, inflammation, and immune responses.
- Macrophages are key players in atherosclerotic plaque development and inflammation.
- Ferroptosis, a form of cell death involving iron and lipid peroxides, influences macrophage function in atherosclerosis.
Purpose of the Study:
- To review the mechanisms linking dysregulated iron handling, lipid metabolism, and redox imbalance to macrophage ferroptosis in atherosclerosis.
- To explore how macrophage ferroptosis contributes to vascular cell dysfunction and atherosclerotic plaque progression.
- To highlight the therapeutic potential of targeting macrophage ferroptosis for atherosclerosis treatment.
Main Methods:
- Literature review of studies on ferroptosis, macrophages, and atherosclerosis.
- Analysis of the interplay between iron metabolism, lipid peroxidation, and oxidative stress in atherosclerotic lesions.
- Examination of the impact of ferroptosis on vascular smooth muscle cells, endothelial cells, and macrophages.
Main Results:
- Dysregulated iron handling, lipid metabolism, and redox imbalances promote macrophage ferroptosis in atherosclerosis.
- Macrophage ferroptosis exacerbates oxidative stress and inflammation, driving plaque formation and instability.
- Ferroptosis contributes to the dysfunction of vascular cells, promoting atherosclerosis progression and increasing cardiovascular event risk.
Conclusions:
- Inhibiting macrophage ferroptosis offers a potential therapeutic strategy to reduce oxidative stress and inflammation.
- Targeting ferroptosis may stabilize atherosclerotic plaques and lower the risk of cardiovascular events.
- Further research into macrophage ferroptosis is crucial for developing novel atherosclerosis treatments.
Related Concept Videos
Inflammation
61.4K
Overview
61.4K
Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Atherosclerosis I: Introduction
765
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
765
Coronary Artery Disease II: Pathophysiology
336
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
336
